關於 target audience research ，我們在網路上蒐集到這些相關的討論、資訊與評價

Are you struggling to come up with what to post on Instagram?

Does content creation feel like stabbing in the dark, trying to see what works and what is not? And often, nothing seems to work.

In short, you have not cracked the code yet.

Let us start by saying there is not one perfect formula or recipe for an Instagram post. But what we can share with you today are some research-based information or guidelines to make your post more interesting and engaging for your target audience.

Find out how you can level up your Instagram Game here:
⬇⬇⬇
www.momboss.academy/iggrowth

【International Live Webinar Series】Strategies for Applying Clinical Trials in Europe歐洲臨床試驗申請策略與佈局

🌍此次學苑特別推出國際線上同步遠距課程，並與德國講師合作，提供學員最新的國際臨床試驗實務課程!
此次課程為系列課程，首堂為”歐洲臨床試驗申請策略與佈局”。對於想往歐洲發展、合作或與歐洲從事臨床試驗的相關公司廠商有很大的幫助!

Date:
Part 1: 2020/12/01 (Tues) 16:30 ~ 18:00 (GMT+8)
Part 2: 2020/12/03 (Thurs) 16:30 ~ 18:00 (GMT+8)
Location：Online Webinar Training
Instructor：Anika Staack, Founder of ARC-TRAICOA / EU-QPPV
【Course Outline】
Part 1 2020/12/01 (Tues) 16:30 ~ 18:00 (GMT+8)
A. Europe – One Union with differences

B. European Clinical Trial Directive
1.Role of national competent authorities
2.Role of ethics committees (central / local)
3.Role of investigator
4.Role of sponsor
5.Role of EMA

C. Planning clinical trials in Europe
1.Analysis of product
a.Indication
b.Patient group
2.Analysis of end points
3 .Analysis of protocol
4.Preparing feasibility
5.Choosing Key Opinion Leaders
6.Sponsor or IIT?
7.Similar studies already running?

Part 2 2020/12/03 (Thurs) 16:30 ~ 18:00 (GMT+8)
A. Applying clinical trial
1.Collecting information you need
2.Establishing study team

B. Required entry into EudraCT

C. Required approval from national HAs and ethics

D. Required fulfilment of national data protection laws

E. Considerations
1.Doing it by yourselves
2.Contracting CRO
3.Auditing

F. Upcoming issues: Site and patient recruitment, site resources, patients withdrawal, protocol amendments

G. Final presentation of study reports

Online Course Fees include 2 Webinars, 90 minutes each：
Special Price $160 USD per Person; Original Price $180 USD
(*1) Certificate of Attendance will be issued only if participants attend both part 1 & 2 webinar
(*2) Certificate of Completed Assessment will be issued only if participant pass the assessment

Register here 👉 https://forms.gle/Kj9yMVynsq7yzSzs8

Organizer：ARC-TRAICOA
Co-Organizer：Salt and Light Institute

【Target Audience】
(1.) Anyone who is interested in clinical trials in Europe
(2.) Anyone who has experience in working in clinical trials related field such as PI,PM,RA,RD,MA,DM,ST,CRA, CRC,QC,QA, etc)

【Instructor CV】
Anika Staack

Current Position:
Founder of ARC-TRAICOA
EU-Qualified Person for Pharmacovigilance (EU-QPPV)
Local German QPPV Consultant and Speaker

Previous Experience:
EU-QPPV / Stufenplanbeauftragte & Group Leader PV at Medice
Senior Drug Safety Manager at ICON
Lead Site Management Associate at PRA
Clinical Research Associate at SKM Oncology

Expertise:
Expertise Databases: European Medicine Agency EudraVigilance and xEVMPD
Quality Assurance: Audits & Inspections, SOP Writing and QA documentation, recalls and product quality
Clinical Trial Management: Feasibility, monitoring, eCRF set-up, database reconciliation, site selection, contract management, patient recruitment, study reports
Authorization process: PSMF, RMP & PSUR Writing, answering authority requests, Risk Management, overseeing product life-cycle

Education Background:
Master of Science (Biology)

Email: bioschool@biotech-edu.com Tel: (+886) 02-2545-9721 ext.18

【Pitching in the Age of COVID-19】

Pitching is a very fundamental skill that we help all of our founders develop. Whether it's to potential employees, clients, or investors, understanding your target audience and crafting your narrative accordingly is a ubiquitous art that is pivotal through all lifecycles of your startup.

But COVID19 has completely redefined the rules of the game. Subtle emotional cues that you would normally pick up through body language and facial expressions have now been washed out by pixelated screens and internet latency. Building rapport through prolonged pleasantries and adhoc chit chat have been mulled over by coronavirus talk and regimented back-to-back virtual meetings.

And if you had a hard time captivating the attention of your audience in person, those efforts are even more likely to be thwarted now with the handful of distractions they literally have at their fingertips from internet browsers to messaging clients to phones.

Having now sat through dozens of virtual pitches, I'd like to pass on 5 tips to keep your audience interested and engaged (specifically geared towards founders pitching investors):

1. Do your homework
I can't stress this enough. This applies both in a pre and post COVID19 world. Leave as much guess work out of the equation by doing as much research on the person you're meeting as possible. If it's an investor, understand the basics of their fund, including fund size, areas of interest, geographic coverage, as well as the investor's background (age, schooling, nationality, etc.). Use these data points as way to build rapport and tailor your pitch accordingly.

2. Send your deck early
A prospective investor may or may not read it. But you have to at least give them that option. For the ones that do, the conversations are guaranteed to become 2x more productive, with an initial field of understanding and questions having already been set. You typically only have 1 hour, so best make use of that time.

3. Streamline your deck
Often times slides are filled with a superfluous amount of information or too many graphics where the main point gets lost in translation. Make sure you can summarize each slide in a one-sentence takeaway, and that each slide helps illustrate either 1) the problem 2) your solution 3) your team 4) your traction. Generally 10 - 12 slides will suffice. Anything extra, put it in the appendix!

4. Insert Q&A breaks
Usually when someone is confused or skeptical, it shows on their face. Less evident on virtual meetings unfortunately. Strategically insert Q&A breaks in your pitch to make sure your audience is on the same page, rather than letting questions pile up till the end. This also helps make the pitch more dynamic, more engaging, and more of a conversation. Studies have also shown that people tend to tune out after 10 minutes, which is why Apple normally swaps out its speakers every 10 minutes or so at its annual WWDC.

5. Practice, practice, practice.
A lot of times it's not so much what you say, but how you say it. Early stage investors are often times betting on feeling as much as rational hypotheses. This means you need to exude a sense of confidence and passion, which may be hard to generate when you're speaking into a camera for 1 hour. Try recording yourself on camera to see how you actually come off and then adjust accordingly.

Furthermore, don't just practice the pitch in and of itself, but also Q&A where a lot of the "sale" actually occurs. This is when investors are testing your wit and execution, to really understand if you know your space and your business, and extracting any insights you may/should have. They're also looking to see if you have a true passion for the problem at hand. Startups are hard. Very hard. If you don't have a strong heart or "why", you will not make it.

5.5 This goes without saying, but when conducting virtual pitches, make sure you have good hygiene, dress appropriately, and are in a quiet place where you won't be distracted by pets, children, or loud chatter.

Happy pitching!

-Jun Wakabayashi
Analyst, AppWorks

If you're startup working in AI, blockchain, or SEA, be sure to apply to AW#21 to join the region's strongest founder community: https://bit.ly/3c1KEUK